Edition:
United Kingdom

Health News Headlines

Merck, Pfizer drug combo extends kidney cancer survival: study

A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those receiving and older Pfizer standalone therapy, according to data from a late-stage study presented on Saturday.

U.S. Medicare plans to track CAR-T cancer therapy outcomes

The U.S. Centers for Medicare & Medicaid Services (CMS) on Friday proposed coverage of expensive CAR-T cell therapies at cancer centers that meet criteria including a registry or clinical study to monitor how well patients fare for at least two years after treatment.

Asthma classes in school may help reduce attacks

(Reuters Health) - School-age children with asthma who receive education on managing the condition may have fewer attacks, emergency room visits and hospitalizations than those who don't get such classes, a recent study suggests.

Business Video

Top News